Acrivon Therapeutics stock price
아크리본 테라퓨틱스NASDAQ:ACRV · Nasdaq · Healthcare$1.99-1.00%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Acrivon Therapeutics last closed at $1.99 (-1.00%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -1.1×. Its overall grade ranks 453 of 739 stocks in Healthcare.
About this company
Acrivon Therapeutics last closed at $1.99 (-1.00%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 453/739
Valuation grade B-
Related stocks
- RocheCompetitor
종양학 신약 개발에서 경쟁하는 글로벌 대형 제약사
- MerckCompetitor
항암제 포트폴리오로 직접 경쟁하는 글로벌 제약사
- Bristol Myers SquibbCompetitor
항암 신약 및 면역항암제 분야의 주요 경쟁사
About Acrivon Therapeutics
- What technical signals does Acrivon Therapeutics (ACRV) have?
- Acrivon Therapeutics current technical signals: no active technical signal.
- Is Acrivon Therapeutics a cup-and-handle pattern?
- No. Acrivon Therapeutics has no valid Cup signal right now.
- What published figures are available for Acrivon Therapeutics?
- Market cap: $62.79M. Trailing 12 months PER: -1.1×. Latest quarter PBR: 0.96×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Acrivon Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy